Metabolic precision labeling enables selective probing of O-linked N-acetylgalactosamine glycosylation
Marjoke F. Debets,
Omur Y. Tastan,
Simon P. Wisnovsky,
Stacy A. Malaker,
Leonhard K. R. Moeckl,
Lauren J. S. Wagner,
William M. Browne,
David C. Briggs,
Holly L. Douglas,
Gaelen T. Hess,
Anthony J. Agbay,
Stuart M. Haslam,
Ambrosius P. Snijders,
Michael C. Bassik,
W. E. Moerner,
Vivian S. W. Li,
Carolyn R. Bertozzi,
Posted 25 Apr 2020
bioRxiv DOI: 10.1101/2020.04.23.057208 (published DOI: 10.1073/pnas.2007297117)
Posted 25 Apr 2020
Protein glycosylation events that happen early in the secretory pathway are often dysregulated during tumorigenesis. These events can be probed, in principle, by monosaccharides with bioorthogonal tags that would ideally be specific for distinct glycan subtypes. However, metabolic interconversion into other monosaccharides drastically reduces such specificity in the living cell. Here, we use a structure-based design process to develop the monosaccharide probe GalNAzMe that is specific for cancer-relevant Ser/Thr-N-acetylgalactosamine (O-GalNAc) glycosylation. By virtue of a branched N-acylamide side chain, GalNAzMe is not interconverted by epimerization to the corresponding N-acetylglucosamine analog like conventional GalNAc-based probes. GalNAzMe enters O-GalNAc glycosylation but does not enter other major cell surface glycan types including Asn (N)-linked glycans. We equip cells with the capacity to biosynthesize the nucleotide-sugar donor UDP-GalNAzMe from a caged precursor. Tagged with a bioorthogonal azide group, GalNAzMe serves as an O-glycan specific reporter in superresolution microscopy, chemical glycoproteomics, a genome-wide CRISPR knock-out (KO) screen, and imaging of intestinal organoids. GalNAzMe is a precision tool that allows a detailed view into the biology of a major type of cancer-relevant protein glycosylation. ### Competing Interest Statement The authors have declared no competing interest.
- Downloaded 952 times
- Download rankings, all-time:
- Site-wide: 14,993 out of 103,802
- In synthetic biology: 236 out of 941
- Year to date:
- Site-wide: 3,103 out of 103,802
- Since beginning of last month:
- Site-wide: 22,142 out of 103,802
Downloads over time
Distribution of downloads per paper, site-wide
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!